Advanced Filters
noise
Found 63,122 clinical trials
Q Qiang Wei, PhD

Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke

The HOPE-MeVO study aims to evaluate the efficacy and safety of intravenous recombinant human prourokinase (rhPro-UK) in patients with acute ischemic stroke due to medium vessel occlusion presenting 4.5 to 24 hours after stroke onset or last known well. Eligible patients will be selected based on CT perfusion imaging and …

18 years of age All Phase 3
A Ayse Ozlem Mete, MD

Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)

Chronic hepatitis B is a long-term viral infection that affects millions of people worldwide. Patients usually require lifelong antiviral treatment to control the virus and prevent liver damage. Some older antiviral medications, such as lamivudine, can lead to the development of viral resistance. This means the virus changes in a …

18 - 80 years of age All Phase N/A
U US GSK Clinical Trials Call Center

A Study to Investigate Mocertatug Rezetecan as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)

The purpose of this study is to see how well mocertatug rezetecan (Mo-Rez) in combination with physician's choice of immunotherapy (dostarlimab or pembrolizumab) works as maintenance therapy in participants with advanced or recurrent endometrial cancer (EC) compared with the physician's choice of immunotherapy (dostarlimab or pembrolizumab) alone, which represents the …

18 years of age Female Phase 3

Evidence Based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU)

The goal of this observational study is to learn about the implementation of a process to review antimicrobial prescriptions for adult patients in Intensive Care Unit (ICU). The main question it aims to answer is: can a structured antimicrobial review can be implemented in ICUs? Implementation will be supported by …

18 years of age All Phase N/A
T Trudy Sea-Eun Kim

Post-market Safety Study of LUMISIGHT

This study is a prospective, multi-center, observational post-market safety study evaluating the incidence of anaphylaxis and hypersensitivity reactions associated with LUMISIGHT (pegulicianine) administration in adults with breast cancer undergoing lumpectomy surgery. Participants are indicated to receive LUMISIGHT as part of their breast cancer care. There is no investigational drug associated …

18 years of age All Phase N/A
Y Yongwhan Lim, M.D

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

The goal of this multicenter, open-label, randomized clinical trial is to learn whether norepinephrine or dopamine is more effective and safer as the first-line vasoactive drug for treating cardiogenic shock in adults. Cardiogenic shock is a life-threatening condition in which the heart cannot pump enough blood to supply the body. …

19 years of age All Phase N/A
F Fleur Wildebeest

Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)

The IMPLEMENT HF study is part of the national heart failure quality of care registry (evaluation of given health care). Within the HF registry, the investigators will investigate whether mirror information on the actual 4 pillars of guideline directed medical therapy (GDMT) in HFrEF patients will help to further improve …

18 years of age All Phase N/A
S Site Public Contact

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

This phase III trial evaluates the effect of adding locoregional therapy (surgery and radiation) and metastasis-directed stereotactic body radiation therapy (SBRT) to standard systemic therapy following standard HER2-targeted systemic therapy, compared to standard systemic therapy alone, in treating patients with HER2-positive stage IV breast cancer that has spread from where …

18 years of age All Phase 3
N Nicole Paraskeva, DHealthPsy

Evaluation of a Brief Influencer-Delivered Body Image Video

A 60-second video will be created by a high-engaging adult female influencer via a partnership with an influencer agency, Dove/Unilever, and CAR to be delivered by the same influencer to her followers on Instagram and TikTok. The video will focus on sharing an evidence-informed exercise to support challenging appearance ideals …

18 years of age Female Phase N/A

Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

The purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines

18 years of age All Phase 2/3

Simplify language using AI